SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Senesac who wrote (224)7/8/1997 1:30:00 AM
From: BulbaMan   of 834
 
Lehman Brothers has set a $16 target for TXB. The Lehman analyst predicts that a "major" pharmaceutical partner will be signed soon for Novastan.
(Don't know if the Lehman target has already been posted here. If so, I figure it doesn't hurt to repeat good news. I read the Lehman info in a two paragraph summary of their report on TXB. If someone has the full report, it would be great if you could post interesting details.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News